RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aspen Pharmacare Holdings Stock

Aspen Pharmacare Holdings Stocks 2024

Aspen Pharmacare Holdings Stocks

444.2 M

Ticker

APN.JO

ISIN

ZAE000066692

WKN

A0ET80

In 2024, Aspen Pharmacare Holdings had 444.2 M outstanding stocks, a 0% change from the 444.2 M stocks in the previous year.

The Aspen Pharmacare Holdings Stocks history

YEARNUMBER OF STOCKS (undefined ZAR)
2027e444.2
2026e444.2
2025e444.2
2024e444.2
2023444.2
2022453
2021456.5
2020456.5
2019456.5
2018456.4
2017456.4
2016456.5
2015456.45
2014456
2013456
2012436
2011454
2010426
2009383
2008375
2007362
2006362
2005358
2004372

Aspen Pharmacare Holdings shares outstanding

The number of shares was Aspen Pharmacare Holdings in 2023 — This indicates how many shares 444.2 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aspen Pharmacare Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aspen Pharmacare Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aspen Pharmacare Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aspen Pharmacare Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aspen Pharmacare Holdings Aktienanalyse

What does Aspen Pharmacare Holdings do?

Aspen Pharmacare Holdings Ltd is a South African company that was founded in 1850 in Durban, South Africa. The company is now one of the largest manufacturers and suppliers of generic drugs in the world and employs over 10,000 people in 55 countries. The company's history dates back to its founder, William Waddell, who opened a pharmacy in Durban in 1850. Over the years, the pharmacy grew into a significant company in the region and expanded to other parts of South Africa in the 1930s. In 1997, the company was renamed Aspen Pharmacare Holdings and began focusing on the production of generic drugs. Aspen Pharma follows a diversified business model based on three pillars: generics, brands, and specialty pharmaceuticals. The company is one of the largest generic drug manufacturers in the world and offers a wide range of generics, including antibiotics, antidepressants, antidiabetics, and cardiovascular medications. The second pillar of the business model is the work in the branded pharmaceuticals sector. For this purpose, Aspen Pharmacare Holdings has a subsidiary called Aspen Global Incorporated, which is responsible for the development, approval, and marketing of patented drugs. Some of Aspen's most well-known branded products include Thrombophob, Emdocam, Bouchara-Recordati, and Zocor. The third pillar of the business model is the specialty pharmaceuticals segment. Here, the company offers medications for specific therapy areas such as cancer, multiple sclerosis, HIV/AIDS, and eye diseases. The company also has its own research and development department to develop and market new drugs. In recent years, Aspen Pharmacare Holdings has experienced impressive expansion. The company has conducted numerous acquisitions and mergers to increase its market presence and diversify its product range. An example of a significant acquisition by Aspen is the purchase of Australian company Sigma Pharmaceuticals in 2011. Through the acquisition of Sigma, Aspen was able to strengthen its role in the Australian market and improve its position in the global pharmaceutical market. In addition to manufacturing and selling drugs, the company also operates a range of other business areas. These include the production of medical devices, the development of medical technology, the manufacturing of biological drugs, and the provision of logistics and distribution services. The company is present in many third-world countries and aims to improve access to affordable medicines worldwide. Aspen has earned an excellent reputation as a pioneer in this field and has been actively involved in numerous projects and initiatives for years to improve healthcare in developing countries. In conclusion, Aspen Pharmacare Holdings is an impressive company with a long history and an extremely diverse product range. The company demonstrates strong growth dynamics while also advocating for improving public health and access to affordable medicines. Given the constantly changing healthcare industry and global threats posed by pandemics and other challenges, Aspen still has significant potential for growth, and the future looks promising. Aspen Pharmacare Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Aspen Pharmacare Holdings's Shares Outstanding

Aspen Pharmacare Holdings's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Aspen Pharmacare Holdings’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Aspen Pharmacare Holdings’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Aspen Pharmacare Holdings’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Aspen Pharmacare Holdings stock

How many stocks are there of Aspen Pharmacare Holdings?

The current number of stocks of Aspen Pharmacare Holdings is 444.2 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Aspen Pharmacare Holdings are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Aspen Pharmacare Holdings evolved in recent years?

The number of shares of Aspen Pharmacare Holdings has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Aspen Pharmacare Holdings as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Aspen Pharmacare Holdings?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Aspen Pharmacare Holdings pay?

Over the past 12 months, Aspen Pharmacare Holdings paid a dividend of 3.42 ZAR . This corresponds to a dividend yield of about 0.02 %. For the coming 12 months, Aspen Pharmacare Holdings is expected to pay a dividend of 3.66 ZAR.

What is the dividend yield of Aspen Pharmacare Holdings?

The current dividend yield of Aspen Pharmacare Holdings is 0.02 %.

When does Aspen Pharmacare Holdings pay dividends?

Aspen Pharmacare Holdings pays a quarterly dividend. This is distributed in the months of October, October, October, October.

How secure is the dividend of Aspen Pharmacare Holdings?

Aspen Pharmacare Holdings paid dividends every year for the past 7 years.

What is the dividend of Aspen Pharmacare Holdings?

For the upcoming 12 months, dividends amounting to 3.66 ZAR are expected. This corresponds to a dividend yield of 0.02 %.

In which sector is Aspen Pharmacare Holdings located?

Aspen Pharmacare Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aspen Pharmacare Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspen Pharmacare Holdings from 9/23/2024 amounting to 0.2 ZAR, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Aspen Pharmacare Holdings pay the last dividend?

The last dividend was paid out on 9/23/2024.

What was the dividend of Aspen Pharmacare Holdings in the year 2023?

In the year 2023, Aspen Pharmacare Holdings distributed 3.26 ZAR as dividends.

In which currency does Aspen Pharmacare Holdings pay out the dividend?

The dividends of Aspen Pharmacare Holdings are distributed in ZAR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aspen Pharmacare Holdings

Our stock analysis for Aspen Pharmacare Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspen Pharmacare Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.